In 2020, research and development spending in the pharmaceutical industry totaled nearly 200 billion U.S. dollars globally. For comparison, R&D expenditures totaled 137 billion dollars in 2012. Pharmaceutical R&D includes all steps from the initial research of disease processes, the compound testing over pre-clinical, and all clinical trial stages. At a certain point in the process – mostly during the pre-clinical phase – a governmental authority is involved to overview, regulate, and ultimately approve the drug. In the United States, the Food and Drug Administration is the principal agency associated with processes.
The pressure to innovate
In comparison to other industries, pharmaceutical companies are more driven by the imperative to manufacture innovative products, and thus to spend significant amounts on research and development. This is largely due to the time-limited patent protection of drugs and the following threat of sales erosion through generic and biosimilar competition. Two major effects of patent expirations for the pharma industry are a specific high R&D intensity and a growing focus on specialty drugs to diversify their product portfolio.
The latest trends
For the last several years, major developments in pharmaceutical research and development have begun to change the R&D landscape. A growing number of drug manufacturers are outsourcing large parts of R&D, mostly to clinical research organizations (also contract research organizations), with the main aim to reduce costs. Another important development is the use of big data in clinical research. Thus, a predictive modeling is possible which uses clinical and molecular data to develop safer and more efficient drugs. Particularly, real-time or real-world evidence (RWE) is becoming a greater interest. This makes cooperation with technology companies necessary and includes data gathered from various sources, even that of social media.
Total global spending on pharmaceutical research and development from 2012 to 2026
(in billion U.S. dollars)
Profit from the additional features of your individual account
Currently, you are using a shared account. To use individual functions (e.g., mark statistics as favourites, set
statistic alerts) please log in with your personal account.
If you are an admin, please authenticate by logging in again.
Statista Accounts:
Access All Statistics. Starting from $468 / Year
Learn more about how Statista can support your business.
Evaluate. (July 30, 2021). Total global spending on pharmaceutical research and development from 2012 to 2026 (in billion U.S. dollars) [Graph]. In Statista. Retrieved July 05, 2022, from https://www.statista.com/statistics/309466/global-r-and-d-expenditure-for-pharmaceuticals/
Evaluate. "Total global spending on pharmaceutical research and development from 2012 to 2026 (in billion U.S. dollars)." Chart. July 30, 2021. Statista. Accessed July 05, 2022. https://www.statista.com/statistics/309466/global-r-and-d-expenditure-for-pharmaceuticals/
Evaluate. (2021). Total global spending on pharmaceutical research and development from 2012 to 2026 (in billion U.S. dollars). Statista. Statista Inc.. Accessed: July 05, 2022. https://www.statista.com/statistics/309466/global-r-and-d-expenditure-for-pharmaceuticals/
Evaluate. "Total Global Spending on Pharmaceutical Research and Development from 2012 to 2026 (in Billion U.S. Dollars)." Statista, Statista Inc., 30 Jul 2021, https://www.statista.com/statistics/309466/global-r-and-d-expenditure-for-pharmaceuticals/
Evaluate, Total global spending on pharmaceutical research and development from 2012 to 2026 (in billion U.S. dollars) Statista, https://www.statista.com/statistics/309466/global-r-and-d-expenditure-for-pharmaceuticals/ (last visited July 05, 2022)